Download presentation
Presentation is loading. Please wait.
Published bySarah McCormick Modified over 8 years ago
1
Cord Blood-Derived Regulatory T Cells: A Novel Cure for Graft-Versus-Host-Disease Siddharth Damania 2007
2
University of Minnesota Cancer Center
3
Bone-Marrow and Stem-Cell Transplants http://www.vacationusarentals.com/images/usa_map.gif 6,000 Americans
4
Bone-Marrow and Stem-Cell Transplants http://www.southalabama.edu/nursing/MSN%20Info/surgery_nurse.jpg
5
Bone-Marrow and Stem-Cell Transplants http://www.southalabama.edu/nursing/MSN%20Info/surgery_nurse.jpg Over half develop GVHD
6
Graft-Versus-Host-Disease (GVHD) GVHD occurs when transplanted cells reject host cells in the patient Patient Cell Transplanted Cell
7
GVHD Purpose To use T-reg cells to cure mice with human GVHD
8
First Goal To devise a new protocol to derive and purify CD4 + 25 + T-reg cells using human umbilical cord blood
9
Types of T cells Cytotoxic T cells Helper T cells T-reg cells http://www.britannica.com/eb/art/print?id=85110&articleTypeId=0
10
CD4 + 25 + T-reg Cells Sakaguchi (2005) –Increased capability to suppress immune responses –Low numbers increase risk of autoimmune diseases
11
CD4 + 25 + T-reg Cells Sakaguchi (2005) –Increased capability to suppress immune responses –Low numbers increase risk of autoimmune diseases Suri-Payer et al (2006) –Potential to suppress multiple types of autoimmune diseases
12
Umbilical Cord Blood Godfrey et al (2005) –T-reg cells isolated from peripheral blood are often impure and require multiple purification processes
13
Umbilical Cord Blood Godfrey et al (2005) –T-reg cells isolated from peripheral blood are often impure and require multiple purification processes –Umbilical cord blood facilitates easier purification and presents purer quantities of T-reg cells
14
Procedure
18
CD4 + 25 + T-reg Cells
19
FACS T-reg Cell Purity (CD4/CD25) 86.2%95.4% 91.5%81.0%
20
Second Goal To culture derived CD4 + 25 + T-reg cells
21
Second Goal To culture derived CD4 + 25 + T-reg cells CD4 + 25 + T-reg Cells
22
Second Goal To culture derived CD4 + 25 + T-reg cells CD4 + 25 + T-reg Cells
23
Second Goal To culture derived CD4 + 25 + T-reg cells CD4 + 25 + T-reg Cells
24
3/28 Cell Line
25
KT32 Cell Line
26
KT32-41BBL Cell Line
27
KT32-OX40L Cell Line
28
Culture Expansion of T-reg Cells
29
Culture Decline of T-reg Cells
30
Third Goal To analyze the histological effect of CD4 + 25 + T-reg cells in GVHD mice
31
Procedure
33
GVHD
34
Procedure GVHD
35
Procedure GVHD
36
Healthy Liver
37
Diseased Liver
42
GVHD Reduction with T-reg Cells
45
50%
46
GVHD Reduction with T-reg Cells 44%
47
GVHD Reduction with T-reg Cells 20%
48
GVHD Reduction with T-reg Cells 45%
49
Future Work Optimize culture expansion
50
Future Work Optimize culture expansion Increase rate of cure in mice
51
Future Work Optimize culture expansion Increase rate of cure in mice Test T-reg cells as a therapeutic cure for GVHD in humans
52
Acknowledgements Dr. Keli Hippen Dr. Paul Harker-Murray The University of Minnesota Lois Fruen Advanced Science Research
53
Cord Blood-Derived Regulatory T Cells: A Novel Cure for Graft-Versus-Host-Disease Siddharth Damania 2007
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.